<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated on Wed, 08 Apr 2026 03:17:42 -0400 -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>    <title>Medexus Pharmaceuticals, Inc. (MDP) - M&eacute;dias</title>
    <link>https://www.medexus.com/fr/actualites-medias/medias</link>
    <description>The latest news released by Medexus Pharmaceuticals, Inc.</description>
    <language>en-us</language>
    <generator>Equisolve</generator>
    <image>
      <url>https://d1io3yog0oux5.cloudfront.net/_048babcf805ec1488832f06f65476ff3/medexusinc/logo.png</url>
      <title>Medexus Pharmaceuticals, Inc.</title>
      <link>https://www.medexus.com</link>
      <width>88</width>
      <height>31</height>
    </image>
    <item>
      <title> Entrevue complète : Medexus Pharmaceuticals annonce un bond dans ses revenus au T1 et une hausse des produits </title>
      <link>https://www.proactiveinvestors.com/companies/news/901662/medexus-pharmaceuticals-unveils-jump-in-1q-revenue-increased-earnings-901662.html</link>
      <pubDate>Wed, 28 Aug 2019 00:00:00 -0400</pubDate>
      <guid isPermaLink="true">https://www.proactiveinvestors.com/companies/news/901662/medexus-pharmaceuticals-unveils-jump-in-1q-revenue-increased-earnings-901662.html</guid>
    </item>
    <item>
      <title>Entrevue complète : Un analyste de Discovery Investment Research déclare que les activités commerciales de Medexus Pharmaceuticals sont robustes</title>
      <link>https://www.proactiveinvestors.com/companies/news/901490/discovery-investment-research-analyst-says-medexus-pharmaceuticals-has-a-solid-business-901490.html</link>
      <pubDate>Mon, 26 Aug 2019 00:00:00 -0400</pubDate>
      <guid isPermaLink="true">https://www.proactiveinvestors.com/companies/news/901490/discovery-investment-research-analyst-says-medexus-pharmaceuticals-has-a-solid-business-901490.html</guid>
    </item>
    <item>
      <title>Medexus Pharmaceuticals affiche d’excellents résultats sur le plan des revenus, et la tendance se maintiendra en 2019</title>
      <link>https://www.proactiveinvestors.com/companies/news/314119/medexus-pharmaceuticals-posts-strong-revenue-numbers-trend-to-continue-in-2019-14119.html</link>
      <pubDate>Wed, 17 Jul 2019 00:00:00 -0400</pubDate>
      <guid isPermaLink="true">https://www.proactiveinvestors.com/companies/news/314119/medexus-pharmaceuticals-posts-strong-revenue-numbers-trend-to-continue-in-2019-14119.html</guid>
    </item>
    <item>
      <title>Medexus Pharmaceuticals commencera à vendre le Treosulfan au Canada et se tournera bientôt vers les É.-U.</title>
      <link>https://www.proactiveinvestors.com/companies/news/312620/medexus-pharmaceuticals-will-begin-selling-treosulfan-in-canada-and-will-soon-look-to-the-us-12620.html</link>
      <pubDate>Fri, 15 Mar 2019 00:00:00 -0400</pubDate>
      <guid isPermaLink="true">https://www.proactiveinvestors.com/companies/news/312620/medexus-pharmaceuticals-will-begin-selling-treosulfan-in-canada-and-will-soon-look-to-the-us-12620.html</guid>
    </item>
  </channel></rss>